Michael W. Boyer

2.5k total citations
29 papers, 700 citations indexed

About

Michael W. Boyer is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Michael W. Boyer has authored 29 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Hematology and 10 papers in Immunology. Recurrent topics in Michael W. Boyer's work include CAR-T cell therapy research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Michael W. Boyer is often cited by papers focused on CAR-T cell therapy research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Michael W. Boyer collaborates with scholars based in United States, Spain and Canada. Michael W. Boyer's co-authors include Edmund K. Waller, Sagar Lonial, Daniel A. Vallera, Bruce R. Blazar, Hilary Rosenthal, Amelia Langston, Jennifer L. Peel, Michael A. Pulsipher, Ingrid Jurickova and Istvan Redei and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Michael W. Boyer

28 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael W. Boyer United States	14	304	299	282	151	131	29	700
Mary Sartor Australia	14	262 0.9×	348 1.2×	184 0.7×	91 0.6×	102 0.8×	36	737
Lujia Dong China	10	239 0.8×	428 1.4×	340 1.2×	94 0.6×	58 0.4×	34	748
Wendy Ingram United Kingdom	13	345 1.1×	608 2.0×	163 0.6×	130 0.9×	191 1.5×	27	864
Katherine Tarlock United States	15	100 0.3×	393 1.3×	355 1.3×	242 1.6×	114 0.9×	53	775
Sujun Gao China	13	216 0.7×	355 1.2×	192 0.7×	133 0.9×	98 0.7×	38	613
Don A. Stevens United States	15	146 0.5×	223 0.7×	469 1.7×	234 1.5×	149 1.1×	100	798
Salyka Sengsayadeth United States	13	140 0.5×	256 0.9×	257 0.9×	148 1.0×	45 0.3×	41	502
Hélène Trebeden‐Negre France	14	305 1.0×	165 0.6×	167 0.6×	94 0.6×	94 0.7×	19	544
James Houston United States	10	461 1.5×	329 1.1×	221 0.8×	65 0.4×	45 0.3×	14	644
James M. Coghill United States	14	666 2.2×	508 1.7×	193 0.7×	115 0.8×	69 0.5×	38	925

Countries citing papers authored by Michael W. Boyer

Since Specialization

Citations

This map shows the geographic impact of Michael W. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Boyer more than expected).

Fields of papers citing papers by Michael W. Boyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Boyer. The network helps show where Michael W. Boyer may publish in the future.

Co-authorship network of co-authors of Michael W. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Boyer. A scholar is included among the top collaborators of Michael W. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Boyer. Michael W. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Laetsch, Theodore W., Shannon L. Maude, Adriana Balduzzi, et al.. (2022). Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia. Leukemia. 36(6). 1508–1515. 26 indexed citations

2.

Laetsch, Theodore W., Gregory A. Yanik, Michael W. Boyer, & Susan R. Rheingold. (2021). An owner's manual for CD19 “CAR”-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia. Blood Reviews. 50. 100848–100848. 6 indexed citations

3.

Ueda, Masumi, Barry E. Storer, Huiying Qiu, et al.. (2020). Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis. Transplantation and Cellular Therapy. 27(2). 163.e1–163.e7.

4.

Stein, Andrew M., Stephan A. Grupp, John E. Levine, et al.. (2019). Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells. CPT Pharmacometrics & Systems Pharmacology. 8(5). 285–295. 102 indexed citations

5.

Laetsch, Theodore W., Shannon L. Maude, Stephan A. Grupp, et al.. (2017). CTL019 Therapy Appears Safe and Effective in Pediatric Patients with Down Syndrome with Relapsed/ Refractory (r/r) Acute Lymphoblastic Leukemia. Blood. 130. 1280–1280. 14 indexed citations

6.

Stein, Andrew M., Stephan A. Grupp, John E. Levine, et al.. (2017). CTL019 Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor (CAR) T Cells to Characterize the Impact of Tocilizumab on Expansion and to Identify Correlates of Cytokine Release Syndrome Severity. Blood. 130. 2561–2561. 3 indexed citations

7.

Bittencourt, Henrique, Susana Rives, Michael W. Boyer, et al.. (2017). Pharmacokinetics and Pharmacodynamics of Tocilizumab for the Management of Cytokine Release Syndrome (CRS) in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Treated with CAR T-Cell Therapy, CTL019. Blood. 130. 2553–2553. 1 indexed citations

8.

Maude, Shannon L., Michael A. Pulsipher, Michael W. Boyer, et al.. (2016). Efficacy and Safety of CTL019 in the First US Phase II Multicenter Trial in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of an Interim Analysis. Blood. 128(22). 2801–2801. 59 indexed citations

9.

Chen, Sophia, et al.. (2015). Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning. International Journal of Hematology. 102(6). 729–731. 1 indexed citations

10.

Rondelli, Damiano, Michael W. Boyer, Tsiporah B. Shore, et al.. (2010). First prospective study of allogeneic peripheral blood stem cell (PBSC) transplantation in patients with myelofibrosis in the United States: Interim analysis of MPD-RC 101 protocol.. Journal of Clinical Oncology. 28(15_suppl). 6535–6535. 3 indexed citations

11.

Adamkiewicz, Thomas V., Paul Szabolcs, Ann E. Haight, et al.. (2007). Unrelated cord blood transplantation in children with sickle cell disease: Review of four‐center experience. Pediatric Transplantation. 11(6). 641–644. 57 indexed citations

12.

Adamkiewicz, Thomas V., Paulette Mehta, Michael W. Boyer, et al.. (2004). Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplantation. 34(5). 405–411. 29 indexed citations

13.

Boyer, Michael W., Thomas G. Gross, Brett Loechelt, et al.. (2003). Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi Anemia. Journal of Pediatric Hematology/Oncology. 25(11). 890–895. 20 indexed citations

14.

Giver, Cynthia R., Jianming Li, David L. Jaye, et al.. (2003). Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. Biology of Blood and Marrow Transplantation. 9(10). 616–632. 27 indexed citations

15.

Waller, Edmund K., Hilary Rosenthal, Jennifer L. Peel, et al.. (2001). Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood. 97(10). 2948–2956. 113 indexed citations

16.

Yeager, Andrew M., Paulette Mehta, Thomas V. Adamkiewicz, et al.. (2000). Unrelated placental/umbilical cord blood cell (UCBC) transplantation in children with high-risk sickle cell disease (SCO). Blood. 96. 5 indexed citations

17.

Waller, Edmund K., et al.. (1999). Irradiated Donor Leukocytes Promote Engraftment of Allogeneic Bone Marrow in Major Histocompatibility Complex Mismatched Recipients Without Causing Graft-Versus-Host Disease. Blood. 94(9). 3222–3233. 5 indexed citations

18.

Waller, Edmund K., et al.. (1999). Irradiated Donor Leukocytes Promote Engraftment of Allogeneic Bone Marrow in Major Histocompatibility Complex Mismatched Recipients Without Causing Graft-Versus-Host Disease. Blood. 94(9). 3222–3233. 51 indexed citations

19.

Blazar, Bruce R., Patricia A. Taylor, Michael W. Boyer, et al.. (1997). CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells. The Journal of Immunology. 159(7). 3460–3473. 57 indexed citations

20.

Boyer, Michael W., Christopher L. Moertel, John R. Priest, & William G. Woods. (1995). Use of intracavitary cisplatin for the treatment of childhood solid tumors in the chest or abdominal cavity.. Journal of Clinical Oncology. 13(3). 631–636. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact